10.46243/jst.2024.v9.i2.pp72-110 registered
Therapeutic Targeting of the SIRT1-SREBP Pathway in Metabolic Disorders
Resolves to https://jst.org.in/index.php/pub/article/view/1460
Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2024.v9.i2.pp72-110
Registered 29 Sep 2026 via crossref · record version 2 · last change 29 Sep 2026, 11:59 PM · record sha256 1042706a6655dc1f…
Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)
Also as schema.org JSON-LD · Turtle · RDF/XML · DataCite XML · Crossref UNIXREF · Crossref UNIXSD — the formats of the DOI content-negotiation service, from this record (which carries what).
What the DOI identifies
JournalArticle — an article in a journal · Digital · Visual · en
Therapeutic Targeting of the SIRT1-SREBP Pathway in Metabolic Disorders (PrincipalTitle · en)
Published 2024-02-02
Part of Journal of Science & Technology · ISSN 2456-5660 · volume 09 · issue 02 · pages 72
Agents
- B Sandhya Rani (author)
- I. Triveni (author)
- B.Revathi (author)
- N. Danamurthy (author)
- Longman Publishers (publisher)
Identifiers DOI 10.46243/jst.2024.v9.i2.pp72-110
Abstract · en
The enzymes known as sirtuins, or silent information regulator 2, are histone deacetylases that depend on nicotinamide adenine dinucleotide (NAD+). In addition to its well-established role in prolonging longevity, further study is necessary to examine the beneficial effects of Sirtuin 1 (SIRT1), a member of the sirtuin group, on lipid metabolism. SIRT1 has been extensively associated with the control of gene expression. The SIRT1 substrate sterol regulatory element-binding protein (SREBP) has garnered a lot of attention because of its involvement in a number of biological processes, such as metabolic activities, DNA damage repair, and cell cycle control. Therefore, the aim of this investigation was to examine and clarify the relationship between SIRT1 and SREBPs and evaluate the role of SIRT1/SREBPs in reducing dysfunction in lipid metabolism. Investigating whether SIRT1 and SREBPs may be used as feasible targets for therapeutic intervention in the management of diabetic complications was the aim of this study.
System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1
Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.
| Element | Value | In the record |
|---|---|---|
| DOI Name DOI name | 10.46243/jst.2024.v9.i2.pp72-110 | doi |
| Referent Type referentType | Creation | referent |
| Referent Sub-Type referentSubType | JournalArticle — an article in a journal | type |
| Referent Name(s) referentName(s) | Therapeutic Targeting of the SIRT1-SREBP Pathway in Metabolic Disorders (PrincipalTitle, en) | titles |
| Basic Metadata basicMetadata | author: B Sandhya Rani author: I. Triveni author: B.Revathi author: N. Danamurthy publisher: Longman Publishers published: 2024-02-02 part of: Journal of Science & Technology · ISSN 2456-5660 · vol. 09 · no. 02 · pp. 72 language: en form: Digital · Visual · Language | agents, dates, container, language, structural_type, modes, characters |
| Referent Identifier(s) alternateIdentifier(s) | none besides the DOI | identifiers, relations (IsSameAs) |
| Registration Authority registrationAuthorityCode | Crossref — issued by Crossref (member 25296); held here as a copy | record.source_agency (our code, ra_doi_name, for names issued here once appointed) |
| Created Date issueDate | 2026-08-26 | record.registered (when the DOI name was first registered) |
| relatedIdentifiers | none needed — the descriptive metadata is in this record | container, relations (only where the descriptive metadata lives at another identifier) |
complete Every System Metadata element is here, with the basic metadata a journal article needs.
The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs
Cited by — in this registry
No record held in this registry cites this DOI.
Counts only records held in this registry; a citation from a work held elsewhere is not seen here. The list as JSON
References with DOIs
The record lists 183 references; 181 carry a DOI.
| # | Reference | DOI | Held here |
|---|---|---|---|
| 1 | ref1 P. Agbu, R.W. Carthew, MicroRNA-mediated regulation of glucose and lipid metabolism, Nat. Rev. Mol. Cell Biol. 22 (2021) 425–438 | 10.1038/s41580-021-00354-w | not held here |
| 3 | ref3 X. Hua, C. Yokoyama, J. Wu, et al., SREBP-2, a second basic-helix-loop-helix- leucine zipper protein that stimulates transcription by binding to a sterol regulatory element, Proc.… | 10.1073/pnas.90.24.11603 | not held here |
| 4 | ref4 X. Wang, R. Sato, M.S. Brown, et al., SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis, Cell 77 (1994) 53–62 | 10.1016/0092-8674(94)90234-8 | not held here |
| 5 | ref5 X. Hua, J. Sakai, Y.K. Ho, et al., Hairpin orientation of sterol regulatory element- binding protein-2 in cell membranes as determined by protease protection, J. Biol. Chem. 270 (… | 10.1074/jbc.270.49.29422 | not held here |
| 6 | ref6 A. Vassilopoulos, K.S. Fritz, D.R. Petersen, et al., The human sirtuin family: evolutionary divergences and functions, Hum. Genom. 5 (2011) 485–496 | 10.1186/1479-7364-5-5-485 | not held here |
| 7 | ref7 W. Giblin, M.E. Skinner, D.B. Lombard, Sirtuins: guardians of mammalian healthspan, Trends Genet 30 (2014) 271–286J. Min, J. Landry, R. Fau-Sternglanz, R. Sternglanz, R.M. Fau-Xu,… | 10.1016/j.tig.2014.04.007 | not held here |
| 8 | ref8 B.J. North, E. Verdin, Sirtuins: Sir2-Relat. NAD-Depend. Protein deacetylases (2004) 224 | 10.1186/gb-2004-5-5-224 | not held here |
| 9 | ref9 E. Seto, M. Yoshida, Erasers of histone acetylation: the histone deacetylase enzymes, Cold Spring Harb. Perspect. Biol. 6 (2014) a018713 | 10.1101/cshperspect.a018713 | not held here |
| 10 | ref10 P. Vong, H. Ouled-Haddou, L. Garçon, Histone Deacetylases Function in the Control of Early Hematopoiesis and Erythropoiesis, Int J. Mol. Sci. 23 (2022) | 10.3390/ijms23179790 | not held here |
| 11 | ref11 V. Kumar, S. Kundu, A. Singh, et al., Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective, Cu… | 10.2174/1570159x19666210609160017 | not held here |
| 12 | ref12 S. Imai, C.M. Armstrong, M. Kaeberlein, et al., Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase, Nature 403 (2000) 795–800 | 10.1038/35001622 | not held here |
| 13 | ref13 R.H. Houtkooper, E. Pirinen, J. Auwerx, Sirtuins as regulators of metabolism and healthspan, Nat. Rev. Mol. Cell Biol. 13 (2012) 225–238 | 10.1038/nrm3293 | not held here |
| 14 | ref14 R.A. Frye, Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins, Biochem Biophys. Res Commun. 273 (2000) 793–798 | 10.1006/bbrc.2000.3000 | not held here |
| 15 | ref15 H. Yuan, R. Marmorstein, Structural basis for sirtuin activity and inhibition, J. Biol. Chem. 287 (2012) 42428–42435V. Carafa, D. Rotili, M. Forgione, et al., Sirtuin functions an… | 10.1074/jbc.r112.372300 | not held here |
| 16 | ref16 Z. Wei, J. Song, G. Wang, et al., Deacetylation of serine hydroxymethyl- transferase 2 by SIRT3 promotes colorectal carcinogenesis, Nat. Commun. 9 (2018), 4468 | 10.1038/s41467-018-06812-y | not held here |
| 17 | ref17 I.C. Chen, W.F. Chiang, S.Y. Liu, et al., Role of SIRT3 in the regulation of redox balance during oral carcinogenesis, Mol. Cancer 12 (2013), 68 | 10.1186/1476-4598-12-68 | not held here |
| 18 | ref18 W. Yao, S. Ji, Y. Qin, et al., Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis, Mol. Cancer 13 (2014), 187 | 10.1186/1476-4598-13-187 | not held here |
| 19 | ref19 D. Xu, H. He, X. Jiang, et al., SIRT2 plays a novel role on progesterone, estradiol and testosterone synthesis via PPARs/LXRα pathways in bovine ovarian granular cells, J. Steroid… | 10.1016/j.jsbmb.2018.07.005 | not held here |
| 20 | ref20 K.H. Fisher-Wellman, J.A. Draper, M.T. Davidson, et al., Respiratory Phenomics across Multiple Models of Protein Hyperacylation in Cardiac Mitochondria Reveals a Marginal Impact o… | 10.1016/j.celrep.2019.01.057 | not held here |
| 21 | ref21 T. Heinonen, E. Ciarlo, D. Le Roy, et al., Impact of the Dual Deletion of the Mitochondrial Sirtuins SIRT3 and SIRT5 on Anti-microbial Host Defenses, Front Immunol. 10 (2019), 2341 | 10.3389/fimmu.2019.02341 | not held here |
| 22 | ref22 G. Nowak, J. Megyesi, Protein kinase Cα mediates recovery of renal and mitochondrial functions following acute injury, Febs J. 287 (2020) 1830–1849, M.C. Haigis, R. Mostoslavsky, … | 10.1111/febs.15110 | not held here |
| 23 | ref23 A. Akkulak, G.D. Yalcin, The interaction of SIRT4 and Calreticulin during ER stress in glia cells, Gene 814 (2022), 146135 | 10.1016/j.gene.2021.146135 | not held here |
| 24 | ref24 G. Cai, Z. Ge, Y. Xu, et al., SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism, Sci. Rep. 12 (2022), 12208 | 10.1038/s41598-022-16610-8 | not held here |
| 26 | ref26 H. Weng, W. Song, K. Fu, et al., Proteomic profiling reveals the potential mechanisms and regulatory targets of sirtuin 4 in 1-methyl-4-phenyl- 1,2,3,6-tet- rahydropyridine-induce… | 10.3389/fnins.2022.1035444 | not held here |
| 27 | ref27 J. Li, H. Zhan, Y. Ren, et al., Sirtuin 4 activates autophagy and inhibits tumorigenesis by upregulating the p53 signaling pathway, Cell Death Differ. 30 (2023) 313–326 | 10.1038/s41418-022-01063-3 | not held here |
| 28 | ref28 X. Quan, Y. Xin, H.L. Wang, et al., Implications of altered sirtuins in metabolic regulation and oral cancer, PeerJ 11 (2023), e14752 | 10.7717/peerj.14752 | not held here |
| 29 | ref29 M.J. Rardin, W. He, Y. Nishida, et al., SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks, Cell Metab. 18 (2013) 920–933 | 10.1016/j.cmet.2013.11.013 | not held here |
| 30 | ref30 T.L. Kawahara, E. Michishita, A.S. Adler, et al., SIRT6 links histone H3 lysine 9 deacetylation to NFkappaB-dependent gene expression and organismal life span, Cell 136 (2009) 62–… | 10.1016/j.cell.2008.10.052 | not held here |
| 31 | ref31 A.R. Chang, C.M. Ferrer, R. Mostoslavsky, SIRT6, a Mammalian Deacylase with Multitasking Abilities, Physiol. Rev. 100 (2020) 145–169 | 10.1152/physrev.00030.2018 | not held here |
| 32 | ref32 Z. Li, K. Xu, N. Zhang, et al., Overexpressed SIRT6 attenuates cisplatin-induced acute kidney injury by inhibiting ERK1/2 signaling, Kidney Int 93 (2018) 881–892 | 10.1016/j.kint.2017.10.021 | not held here |
| 33 | ref33 V.I. Kuznetsov, W.H. Liu, M.A. Klein, et al., Potent Activation of NAD( +)- Dependent Deacetylase Sirt7 by Nucleosome Binding, ACS Chem. Biol. 17 (2022) 2248–2261 | 10.1021/acschembio.2c00348 | not held here |
| 34 | ref34 S. Pande, S. Raisuddin, Molecular and cellular regulatory roles of sirtuin protein, Crit. Rev. Food Sci. Nutr. (2022) 1–19 | 10.1080/10408398.2022.2070722 | not held here |
| 35 | ref35 L. Li, L. Shi, S. Yang, et al., SIRT7 is a histone desuccinylase that functionally links to chromatin compaction and genome stability, Nat. Commun. 7 (2016), 12235 | 10.1038/ncomms12235 | not held here |
| 36 | ref36 X. Bao, Z. Liu, W. Zhang, et al., Glutarylation of histone h4 lysine 91 regulates chromatin dynamics, e669, Mol. Cell 76 (2019) 660–675 | 10.1016/j.molcel.2019.08.018 | not held here |
| 37 | ref37 W. Stünkel, R.M. Campbell, Sirtuin 1 (SIRT1): the misunderstood HDAC, J. Biomol. Screen 16 (2011) 1153–1169 | 10.1177/1087057111422103 | not held here |
| 38 | ref38 Y. Yao, W. Zhang, R. Ming, et al., Noninvasive 40-Hz light flicker rescues circadian behavior and abnormal lipid metabolism induced by acute ethanol exposure via improving SIRT1 a… | 10.3389/fphar.2020.00355 | not held here |
| 39 | ref39 S. Venkatasubramanian, R.M. Noh, S. Daga, et al., Cardiovascular effects of a novel SIRT1 activator, SRT2104, in otherwise healthy cigarette smokers, J. Am. Heart Assoc. 2 (2013),… | 10.1161/jaha.113.000042 | not held here |
| 40 | ref40 M. Kurano, K. Tsukamoto, T. Shimizu, et al., Apolipoprotein M/sphingosine 1- phosphate protects against diabetic nephropathy, Transl. Res (2023) 16–34 | 10.1016/j.trsl.2023.02.004 | not held here |
| 41 | ref41 Y. Fu, Y. Sun, M. Wang, et al., Elevation of JAML promotes diabetic kidney disease by modulating podocyte lipid metabolism, e1058, Cell Metab. 32 (2020) 1052–1062 | 10.1016/j.cmet.2020.10.019 | not held here |
| 42 | ref42 L. Zhang, R. Tu, Y. Wang, et al., Early-Life exposure to lead induces cognitive impairment in elder mice targeting SIRT1 phosphorylation and oxidative alterations, Front Physiol. … | 10.3389/fphys.2017.00446 | not held here |
| 43 | ref43 M. Eid, V. Dzreyan, S. Demyanenko, Sirtuins 1 and 2 in the acute period after photothrombotic stroke: expression, localization and involvement in apoptosis, Front Physiol. 13 (202… | 10.3389/fphys.2022.782684 | not held here |
| 44 | ref44 T. Jiang, T. Qin, P. Gao, et al., SIRT1 attenuates blood-spinal cord barrier disruption after spinal cord injury by deacetylating p66Shc, Redox Biol. 60 (2023), 102615 | 10.1016/j.redox.2023.102615 | not held here |
| 45 | ref45 Y. Yu, X. Song, X. Wang, et al., Oxidative stress impairs the Nur77-Sirt1 axis resulting in a decline in organism homeostasis during aging, Aging Cell (2023), e13812 | 10.1111/acel.13812 | not held here |
| 46 | ref46 X. Song, F. Kong, Z. Zong, et al., miR-124 and miR-142 enhance cisplatin sensitivity of non-small cell lung cancer cells through repressing autophagy via directly targeting SIRT1,… | 10.1039/c8ra09914f | not held here |
| 47 | ref47 S.H. Dai, L.J. Chen, W.H. Qi, et al., microRNA-145 Inhibition Upregulates SIRT1 and Attenuates Autophagy in a Mouse Model of Lung Ischemia/ Reperfusion Injury via NF-κB-dependent … | 10.1097/tp.0000000000003435 | not held here |
| 48 | ref48 W. Dong, H. Zhang, C. Zhao, et al., Silencing of miR-150-5p ameliorates diabetic nephropathy by targeting SIRT1/p53/AMPK Pathway, Front Physiol. 12 (2021), 624989 | 10.3389/fphys.2021.624989 | not held here |
| 49 | ref49 H.G. Zhang, F.J. Wang, Y. Wang, et al., lncRNA GAS5 inhibits malignant progression by regulating macroautophagy and forms a negative feedback DOI:https://doi.org/10.46243/jst.2024… | 10.3892/or.2020.7825 | not held here |
| 50 | ref50 Y. Xu, W. Wan, Acetylation in the regulation of autophagy, Autophagy 19 (2023) 379–387 | 10.1080/15548627.2022.2062112 | not held here |
| 51 | ref51 Y. Wang, R. Zhao, C. Wu, et al., Activation of the sirtuin silent information regulator 1 pathway inhibits pathological myocardial remodeling, Front Pharm. 14 (2023), 1111320 | 10.3389/fphar.2023.1111320 | not held here |
| 52 | ref52 H.H. Chen, Y.X. Zhang, J.L. Lv, et al., Role of sirtuins in metabolic disease-related renal injury, Biomed. Pharm. 161 (2023), 114417 | 10.1016/j.biopha.2023.114417 | not held here |
| 53 | ref53 H. Kang, S. Kim, J.Y. Lee, et al., Inhibitory effects of ginsenoside compound K on lipopolysaccharidestimulated inflammatory responses in macrophages by regulating sirtuin 1 and h… | 10.3390/nu15071626 | not held here |
| 54 | ref54 C. Sun, S. Bai, Y. Liang, et al., The role of Sirtuin 1 and its activators in age-related lung disease, Biomed. Pharm. 162 (2023), 114573 | 10.1016/j.biopha.2023.114573 | not held here |
| 55 | ref55 Miranda-Gonçalves, V. Lameirinhas, A. Macedo-Silva C, et al., Lactate Increases Renal Cell Carcinoma Aggressiveness through Sirtuin 1-Dependent Epithelial Mesenchymal Transition A… | 10.3390/cells9041053 | not held here |
| 56 | ref56 X.J. Yu, X.Z. Guo, C. Li, et al., SIRT1-ZEB1positive feedback promotes epithelial- mesenchymal transition process and metastasis of osteosarcoma, J. Cell Biochem 120 (2019) 3727–3… | 10.1002/jcb.27653 | not held here |
| 57 | ref57 A. Latifkar, L. Ling, A. Hingorani, et al., Loss of sirtuin 1 alters the secretome of breast cancer cells by impairing lysosomal integrity, e397, Dev. Cell 49 (2019) 393–408 | 10.1016/j.devcel.2019.03.011 | not held here |
| 58 | ref58 Y. Liang, X. Song, Y. Li, et al., A novel long noncoding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer, Cell Death Dis. 9 (2018), 563 | 10.1038/s41419-018-0582-1 | not held here |
| 59 | ref59 K. Rifaï, G. Judes, M. Idrissou, et al., SIRT1dependent epigenetic regulation of H3 and H4 histone acetylation in human breast cancer, Oncotarget 9 (2018) 30661–30678 | 10.18632/oncotarget.25771 | not held here |
| 60 | ref60 A. Kuno, R. Hosoda, M. Tsukamoto, et al., SIRT1 in the cardiomyocyte counteracts doxorubicininduced cardiotoxicity via regulating histone H2AX, Cardiovasc Res 118 (2023) 3360–3373 | 10.1093/cvr/cvac026 | not held here |
| 61 | ref61 M.S. Lee, Y. Kim, Chrysanthemum morifolium Flower Extract Inhibits Adipogenesis of 3T3-L1 Cells via AMPK/SIRT1 Pathway Activation, Nutrients 12 (2020) 2726 | 10.3390/nu12092726 | not held here |
| 62 | ref62 M. Park, H. Baek, J.Y. Han, et al., Stevioside Enhances the Anti-Adipogenic Effect and β-Oxidation by Activating AMPK in 3T3-L1 Cells and Epididymal Adipose Tissues of db/db Mice,… | 10.3390/cells11071076 | not held here |
| 63 | ref63 Z. Chai, Y. Yan, S. Zan, et al., Probioticfermented blueberry pomace alleviates obesity and hyperlipidemia in high-fat diet C57BL/6J mice, Food Res Int 157 (2022), 111396 | 10.1016/j.foodres.2022.111396 | not held here |
| 64 | ref64 J. Bai, T. Yang, Y. Zhou, et al., Octacosanol modifies obesity, expression profile and inflammation response of hepatic tissues in high-fat diet mice, Foods 11 (2022) 1606 | 10.3390/foods11111606 | not held here |
| 65 | ref65 R.A. DeBose-Boyd, J. Ye, SREBPs in lipid metabolism, insulin signaling, and beyond, Trends Biochem Sci. 43 (2018) 358–368 | 10.1016/j.tibs.2018.01.005 | not held here |
| 66 | ref66 X. Hua, A. Nohturfft, J.L. Goldstein, et al., Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein, Cell 87 (1996) 415–426 | 10.1016/s0092-8674(00)81362-8 | not held here |
| 67 | ref67 J. Sakai, A. Nohturfft, D. Cheng, et al., Identification of complexes between the COOHterminal domains of sterol regulatory elementbinding proteins (SREBPs) and SREBP cleavageacti… | 10.1074/jbc.272.32.20213 | not held here |
| 68 | ref68 A. Nohturfft, M.S. Brown, J.L. Goldstein, Topology of SREBP cleavage-activating protein, a polytopic membrane protein with a sterol-sensing domain, J. Biol. Chem. 273 (1998) 17243… | 10.1074/jbc.273.27.17243 | not held here |
| 69 | ref69 X. Hua, J. Wu, J.L. Goldstein, et al., Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosom… | 10.1016/0888-7543(95)80009-b | not held here |
| 70 | ref70 I. Shimomura, H. Shimano, J.D. Horton, et al., Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cu… | 10.1172/jci119247 | not held here |
| 71 | ref71 D. Eberl´e, B. Hegarty, P. Bossard, et al., SREBP transcription factors: master regulators of lipid homeostasis, Biochimie 86 (2004) 839–848, M.S. Brown, J.L. Goldstein, The SREBP… | 10.1016/j.biochi.2004.09.018 | not held here |
| 72 | ref72 H. Shimano, J.D. Horton, I. Shimomura, et al., Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured … | 10.1172/jci119248 | not held here |
| 73 | ref73 J. Kotzka, B. Knebel, H. Avci, et al., Phosphorylation of sterol regulatory element- binding protein (SREBP)-1a links growth hormone action to lipid metabolism in hepatocytes, Ath… | 10.1016/j.atherosclerosis.2010.08.046 | not held here |
| 74 | ref74 Y. An, D.D. Zhang, H.L. Yu, et al., 27-Hydroxycholesterol regulates cholesterol synthesis and transport in C6 glioma cells, Neurotoxicology 59 (2017) 88–97 | 10.1016/j.neuro.2017.02.001 | not held here |
| 75 | ref75 J.D. Horton, J.L. Goldstein, M.S. Brown, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, J. Clin. Invest 109 (2002) 1125–1131 | 10.1172/jci0215593 | not held here |
| 76 | ref76 M. Ruiz, R. Devkota, D. Panagaki, et al., Sphingosine 1-phosphate mediates adiponectin receptor signaling essential for lipid homeostasis and embryogenesis, Nat. Commun. 13 (2022)… | 10.1038/s41467-022-34931-0 | not held here |
| 77 | ref77 W.J. Chen, W.K. Huang, S.R. Pather, et al., Podocalyxin-Like protein 1 regulates pluripotency through the cholesterol biosynthesis pathway, Adv. Sci. (Weinh.) 10 (2022), e2205451 | 10.1002/advs.202205451 | not held here |
| 78 | ref78 V. Sengottuvel, M. Hota, J. Oh, et al., Deficiency in the omega-3 lysolipid transporter Mfsd2a leads to aberrant oligodendrocyte lineage development and hypomyelination, J. Clin. … | 10.1172/jci164118 | not held here |
| 79 | ref79 R. Ganji, J.A. Paulo, Y. Xi, et al., The p97-UBXD8 complex regulates ER-Mitochondria contact sites by altering membrane lipid saturation and composition, Nat. Commun. 14 (2023), 6… | 10.1038/s41467-023-36298-2 | not held here |
| 80 | ref80 J.Y. Kim, L.Q. Wang, V.C. Sladky, et al., PIDDosome-SCAP crosstalk controls high- fructosediet-dependent transition from simple steatosis to steatohepatitis, e1546, Cell Metab. 34… | 10.1016/j.cmet.2022.08.005 | not held here |
| 81 | ref81 G. Li, H. Chen, F. Shen, et al., Targeting hepatic serine-arginine protein kinase 2 ameliorates alcoholassociated liver disease by alternative splicing control of lipogenesis, Hep… | 10.1097/hep.0000000000000433 | not held here |
| 82 | ref82 X. Fang, J. Zhang, Y. Li, et al., Malic Enzyme 1 as a Novel Anti-Ferroptotic Regulator in Hepatic Ischemia/Reperfusion Injury, Adv. Sci. (Weinh.) 10 (2023), e2205436, J.Q. Wang, L… | 10.1002/advs.202370079 | not held here |
| 83 | ref83 D. Wu, Y. Yang, Y. Hou, et al., Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin … | 10.1002/cac2.12247 | not held here |
| 84 | ref84 A. Husain, Y.T. Chiu, K.M. Sze, et al., Ephrin-A3/ EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma, J. Hepatol. 7… | 10.1016/j.jhep.2022.02.018 | not held here |
| 85 | ref85 H.M. Lee, A. Nayak, J. Kim, A new role for ammonia in tumorigenesis, Cell Metab. 34 (2022) 944–946 | 10.1016/j.cmet.2022.06.009 | not held here |
| 86 | ref86 C. Cheng, F. Geng, Z. Li, et al., Ammonia stimulates SCAP/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth, Nat. Metab. 4 (2022) 575–588 | 10.1038/s42255-022-00568-y | not held here |
| 87 | ref87 I. Mahmud, G. Tian, J. Wang, et al., DAXX drives de novo lipogenesis and contributes to tumorigenesis, Nat. Commun. 14 (2023), 1927 | 10.1038/s41467-023-37501-0 | not held here |
| 88 | ref88 W. Dai, W. Xiang, L. Han, et al., PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism, Cancer Commun. (Lond.) 42 (2022) 848–867 | 10.1002/cac2.12341 | not held here |
| 89 | ref89 L. Xue, H. Qi, H. Zhang, et al., Targeting SREBP- 2-Regulated Mevalonate Metabolism for Cancer Therapy, Front Oncol. 10 (2020), 1510 | 10.3389/fonc.2020.01510 | not held here |
| 90 | ref90 M. Arito, T. Horiba, S. Hachimura, et al., Growth factor-induced phosphorylation of sterol regulatory element-binding proteins inhibits sumoylation, thereby stimulating the expres… | 10.1074/jbc.m800910200 | not held here |
| 91 | ref91 P.F. Lebeau, J.H. Byun, K. Platko, et al., Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearance, Nat. Commun. 13 (2022), 770 | 10.1038/s41467-022-28240-9 | not held here |
| 92 | ref92 Z. Lu, L. Huang, Y. Li, et al., Fine-tuning of cholesterol homeostasis controls erythroid differentiation, Adv. Sci. (Weinh.) 9 (2022), e2102669 | 10.1002/advs.202102669 | not held here |
| 93 | ref93 J. Chen, H. Zhang, L. Li, et al., Lp-PLA(2) (Lipoprotein-associated phospholipase a (2)) deficiency lowers cholesterol levels and protects against atherosclerosis in rabbits, Arte… | 10.1161/atvbaha.122.317898 | not held here |
| 94 | ref94 H. Liu, M. Hallauer Hastings, R. Kitchen, et al., Beneficial effects of moderate hepatic activin a expression on metabolic pathways, inflammation, and atherosclerosis, Arterioscle… | 10.1161/atvbaha.122.318138 | not held here |
| 95 | ref95 H.M. Cheng, M. Xing, Y.P. Zhou, et al., HSP90β promotes osteoclastogenesis by dual-activation of cholesterol synthesis and NF-κB signaling, Cell Death Differ. 30 (2023) 673–686 | 10.1038/s41418-022-01071-3 | not held here |
| 96 | ref96 W. Tang, J. Zhou, W. Yang, et al., Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver, Cell Mol… | 10.1038/s41423-022-00872-3 | not held here |
| 97 | ref97 H. Zou, Y. Yang, Z. Shi, et al., Nuclear receptor RORγ inverse agonists/antagonists display tissue- and gene-context selectivity through distinct activities in altering chromatin … | 10.1016/j.phrs.2022.106324 | not held here |
| 98 | ref98 E. Branche, Y.T. Wang, K.M. Viramontes, et al., SREBP2-dependent lipid gene transcription enhances the infection of human dendritic cells by Zika virus, Nat. Commun. 13 (2022), 53… | 10.1038/s41467-022-33041-1 | not held here |
| 99 | ref99 H. Shimano, J.D. Horton, R.E. Hammer, et al., Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a, J. C… | 10.1172/jci118951 | not held here |
| 100 | ref100 W. Chen, L. Wen, Y. Bao, et al., Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and upregulating SREBP2, Proc. Natl. Acad. Sc… | 10.1073/pnas.2203894119 | not held here |
| 101 | ref101 C. Zheng, Y. Zhu, Q. Liu, et al., Maprotiline suppresses cholesterol biosynthesis and hepatocellular carcinoma progression through direct targeting of CRABP1, Front Pharm. 12 (202… | 10.3389/fphar.2021.689767 | not held here |
| 102 | ref102 Y.Y. Chen, J.Y. Ge, S.Y. Zhu, et al., Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis, Nat. Commun. 13 (20… | 10.1038/s41467-022-28452-z | not held here |
… and 81 more in the JSON.
Relations
The record states no relation, and no record held here states one with this DOI.
Funding
The record names no funder.
Each funder's page lists every work held here that names it. ROR IDs open at ror.org; Funder Registry IDs resolve at doi.org.
History — the ledger
Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.
| # | When | What | By | Changes |
|---|---|---|---|---|
| 1 | 29 Sep 2026, 10:00 PM | register registered at Crossref; record read from api.crossref.org | Administrator (admin) | 610 fields set · sha256 fcf3491e3048… |
| 2 | 29 Sep 2026, 11:59 PM | update record re-read from api.crossref.org | Administrator (admin) | container.titles.0.value: |
Machine-readable: the history as JSON, with the full record after each change.
Changes made at Crossref through DOI Doctor
Every deposit Smart Scholars' DOI Doctor made for this DOI, oldest first, with Crossref's own answer. Each fingerprint is the SHA-256 of its entry and of the fingerprint before it, so a change to any earlier entry changes every fingerprint after it.
| When | What changed | Crossref | Fingerprint |
|---|---|---|---|
| 21 Sep 2026, 01:50 | Metadata completed publication date | ● accepted by Crossref | dfcd1dc1925b… |
| 21 Sep 2026, 02:50 | Read back: Crossref's record shows it | ● confirmed | 6b5fcd8b74fb… |
2 entries · the last fingerprint 6b5fcd8b74fb20f242ed5932c49b212f9b2a1b0bf010fd75145892c400ea0f8f · the history as JSON, each entry with the fingerprint before it, to check them yourself.



